ArticleScientific reports2026
A multiscale spatio-temporal convolutional attention network for depressive disorder diagnosis via coarse-grained signal reconstruction based on EEG.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Depression disorder (DD) is a common mental disorder and a leading contributor to the global burden of disease. However, accurate diagnosis remains challenging due to the reliance of conventional approaches on subjective assessments. To address this limitation, this study proposes a Multiscale Spatio-temporal Convolutional Attention Network (MSTANet) for EEG-based depression detection. The proposed framework integrates multiscale coarse-grained signal reconstruction with localized spatio-temporal attention modeling, where the spatial dimension explicitly captures inter-channel relationships between bilateral frontal EEG signals (Fp1 and Fp2). MSTANet adopts a multi-parallel convolutional architecture combined with Squeeze-and-Excitation (SE) modules and a fully convolutional network (FCN), enabling effective multiscale spatio-temporal feature learning while maintaining a simplified dual-channel frontal EEG acquisition scheme for improved clinical practicality. Ablation and comparative experiments demonstrate that the proposed model outperforms existing methods, achieving an accuracy of 93.61%. To further assess robustness and clinical generalizability, a dual-center validation scheme was conducted. The model was developed exclusively on the HZTPH Dataset (N = 80) and evaluated on a completely independent external cohort from the JHSH Dataset (N = 230), which was not involved in training, validation, or parameter optimization. MSTANet achieved 93.61% accuracy on the development dataset and maintained 90.21% accuracy on the external validation cohort, exhibiting a minimal cross-center performance degradation. Overall, this study presents a robust and clinically feasible EEG-based depression detection framework, highlighting the translational potential of coarse-grained deep learning with an optimized dual-channel frontal EEG configuration for large-scale screening applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.